There’s no end to ambition and arrogance, which led—again—to a stupefying $96 million upfront CAR-T deal that has blown up even before its close. Here’s what James Sabry, Roche’s new Global Head of Partnering, stated about the deal in August, only 2 months ago. Continue reading There’s no end …
All posts by Jan Mellegers
Members Only
BLOGBU$TER combines cutting edge drug development expertise with the utmost focus: we leverage shared knowledge of a dedicated group of preeminent biotech professionals to invest in the world’s single-best company. For further info: check ‘About The Author.’
Recent Posts:
October 16, 2018: Yankee–Doodle …
October 14, 2018: Ready for the Continue reading Members Only